Search Results 881-890 of 15098 for Cornea

1. Efficacy And Safety Of INCB054828 In Subjects With Advanced/Metastatic Or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - Mayo Clinic

   Current evidence of clinically significant corneal or retinal disorder confirmed by ophthalmologic examination. Use of any potent CYP3A4 inhibitors or ...

2. Mayo Clinic Department of Ophthalmology - Doctors

   Find an ophthalmologist at Mayo Clinic, which has one of the largest and most experienced practices in the U.S and includes dozens of specialties.

3. Albinism - Symptoms and causes - Mayo Clinic

   In this group of inherited disorders, the body makes little or no melanin, a pigment that determines hair, skin and eye color and vision development.

4. DS-8201a In Human Epidermal Growth Factor Receptor2 (HER2)-Expressing Colorectal Cancer (DESTINY-CRC01) - Mayo Clinic

   Has clinically significant corneal disease in the opinion of the investigator. Has spinal cord compression or clinically active central nervous system ...

5. Transition To KPL-387 Monotherapy Dosing & Administration Study - Mayo Clinic

   * Has had an organ transplant (except corneal transplant performed more than 3 months prior to first study drug administration). * In the Investigator's ...

6. Publications - Erinn Downs, D.O. - Mayo Clinic

   Cornea. 2006 Oct; 25 (9):1097-9. View PubMed; Lam MM, Corless CL, Goldblum JR, Heinrich MC, Downs-Kelly E, Rubin BP. Extragastrointestinal stromal tumors ...

7. A Study Of Anetumab Ravtansine As 2nd Line Treatment For Malignant Pleural Mesothelioma - Mayo Clinic

   Patients with corneal epitheliopathy or any eye disorder that may predispose the patients to this condition at the discretion of the ophthalmologist ...

8. Mayo Clinic Department of Ophthalmology - Doctors

   Find an ophthalmologist at Mayo Clinic, which has one of the largest and most experienced practices in the U.S and includes dozens of specialties.

9. Daily Oral Regorafenib For Chemotherapy-Refractory, Metastatic And Locally Advanced Angiosarcoma - Mayo Clinic

   History of organ allograft (including corneal transplant). Known or suspected allergy or hypersensitivity to any of the study drugs, study drug classes, or ...

10. Study To Investigate The Safety And Effectiveness Of Two Doses Of The Antibody Drug GSK2857916 In Relapsed/Refractory Multiple Myeloma Patients - Mayo Clinic

    Current corneal epithelial disease except mild punctate keratopathy. Use of an investigational drug within 14 days or five half-lives, whichever is shorter ...